港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元加速商业化及创新药研发

智通财经2025-07-16

智通财经APP获悉，亚盛医药(06855)午前涨超4%，截至发稿，涨4.11%，报74.75港元，成交额4.95亿港元。消息面上，亚盛医药近日宣布，拟按每股68.60港元的价格发行最多2200万股新股，配售事项所得净额约为14.93亿港元。募集资金约40%将用于商业化工作，包括扩大覆盖范围和提高患者就医机会；约35%将用于全球临床开发，以推进本公司的核心管线在研产品；约25%将用于基础设施及营运...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551111185?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-16 11:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551111185","market":"hk","top_or_hot":-1,"title":"港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，亚盛医药(06855)午前涨超4%，截至发稿，涨4.11%，报74.75港元，成交额4.95亿港元。消息面上，亚盛医药近日宣布，拟按每股68.60港元的价格发行最多2200万股新股，配售事项所得净额约为14.93亿港元。募集资金约40%将用于商业化工作，包括扩大覆盖范围和提高患者就医机会；约35%将用于全球临床开发，以推进本公司的核心管线在研产品；约25%将用于基础设施及营运...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1318372.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-16 11:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1318372.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，亚盛医药(06855)午前涨超4%，截至发稿，涨4.11%，报74.75港元，成交额4.95亿港元。消息面上，亚盛医药近日宣布，拟按每股68.60港元的价格发行最多2200万股新股，配售事项所得净额约为14.93亿港元。募集资金约40%将用于商业化工作，包括扩大覆盖范围和提高患者就医机会；约35%将用于全球临床开发，以推进本公司的核心管线在研产品；约25%将用于基础设施及营运...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1318372.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1318372.html","article_id":"2551111185","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551111185","pubTimestamp":1752638052,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，亚盛医药午前涨超4%，截至发稿，涨4.11%，报74.75港元，成交额4.95亿港元。消息面上，亚盛医药近日宣布，拟按每股68.60港元的价格发行最多2200万股新股，配售事项所得净额约为14.93亿港元。董事认为，配售事项及认购事项将进一步巩固本集团的财务状况，并为本集团提供额外营运资金。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","BK1161":"生物科技","06855":"亚盛医药-B","BK1574":"生物医药B类股","BK4139":"生物科技","06978":"永泰生物-B","AAPG":"亚盛医药"},"translate_title":"Changes in Hong Kong stocks | Ascentage Pharma (06855) rose more than 4% before noon. The company raised nearly HK $1.5 billion in net rights issue to accelerate commercialization and innovative drug research and development","themeId":"4e7834c15c47c74e9bfd4d734ca81974","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"AAPG":1,"06978":1,"06855":1},"content_text":"智通财经APP获悉，亚盛医药(06855)午前涨超4%，截至发稿，涨4.11%，报74.75港元，成交额4.95亿港元。消息面上，亚盛医药近日宣布，拟按每股68.60港元的价格发行最多2200万股新股，配售事项所得净额约为14.93亿港元。募集资金约40%将用于商业化工作，包括扩大覆盖范围和提高患者就医机会；约35%将用于全球临床开发，以推进本公司的核心管线在研产品；约25%将用于基础设施及营运资金以加强全球营运。董事认为，配售事项及认购事项为本公司进一步筹集资金的良机，使本公司可商业化新获批准的核心产品、筹备其他待批准核心产品的商业化并推进早期化合物完成其开发周期，同时可扩大其股东基础。董事认为，配售事项及认购事项将进一步巩固本集团的财务状况，并为本集团提供额外营运资金。配售事项及认购事项所筹集的资金将使本公司能够继续开发其在研产品，包括推进临床关键研究及为新获批准产品的商业化做准备。此外，本公司有多个早期在研产品需要进一步开发，需要持续从市场筹集资金以支持该等工作。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551111185","isCrawlerRequest":true}

港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元 加速商业化及创新药研发

精彩评论

港股异动 | 亚盛医药(06855)午前涨超4% 公司配股净筹近15亿港元加速商业化及创新药研发